IFNG and tuberculosis: Altogether, considering the IFNγ-producing activity and phenotypic changes of the HLA-DR-expressing NK cells in response to interaction with destroyed M. tuberculosis, and, above all, the ability to present mycobacterial antigens, pre-activated in vitro HLA-DR+ NK cells may be considered a subset of potential interest to be targeted by anti-tuberculosis therapy.